FIELD: medicine. SUBSTANCE: invention proposes the use of 2-amino-6-trifluoromethoxybenzothazole or its salt in combination with pharmaceutically acceptable acid as a drug for treatment of lateral amyotrophic sclerosis and, especially, lateral amyotrophic sclerosis with bulbar onset or its bulbar form. EFFECT: enhanced effectiveness of treatment. 3 cl
Authors
Dates
1998-05-10—Published
1992-10-22—Filed